Andrew Aromando - 28 Apr 2023 Form 3 Insider Report for Ambrx Biopharma Inc.

Role: Chief Operating Officer
Signature: /s/ Sonja Nelson, Attorney-in-Fact for Andrew Aromando
Issuer symbol: N/A
Transactions as of: 28 Apr 2023
Net transactions value: $0
Form type: 3
Filing time: 05 May 2023, 16:05:16 UTC
Next filing: 07 Jul 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

See Exhibit 24 for power of attorney.